Penn’s one-stop solution for technology commercialization and entrepreneurship
I’m a Faculty Member or Researcher
I’m with a Company
I’m an Entrepreneur
I want to:
Translating Discoveries
PCI helps to translate discoveries and ideas created at the University of Pennsylvania into new products and businesses for societal benefit.
We actively facilitate a broad range of technology development connections between Penn and the private sector. Whether the end result is a technology license, an R&D alliance, or the formation of a new venture, PCI serves as a dedicated one-stop shop for commercial partnering with Penn.
Access the FY2025 Year in Review
#1
in licensing revenue 5th year in a row
26
Startups launched
>$591M
in investment capital raised or received by Penn affiliated startups
99
New patents awarded
April is AI Month at Penn
AI Month at Penn is a month-long, University-wide initiative throughout April 2026 that will focus on human-centered AI. The month’s events will highlight research, dialogues and collaborations that put people at the center of technological innovation. Learn more and register for events here.
Penn Startups Raising Money
Discover over forty Penn startup companies raising capital in 2026. Read the list here.
Open Source Software
Download our latest Faculty Guide to Open-Source Software Licenses here.
Explore More
Access Penn’s New Inpart Portal
Discover select technologies on Inpart and connect with us for collaboration opportunities.
Access the portalRead the Latest News from PCI on LinkedIn
Available Technologies
Find technology opportunities by sector or search:
Nanotechnology | Antibody | Optics & Photonics | Medical Devices | COVID-19 | Immunology | Oncology | Materials | Bioengineering | Neurodegenerative Diseases
View all technologies
Recent News
All NewsCapstan Therapeutics Acquired by AbbVie for $2.1B
Penn Medicine’s Kiran Musunuru Featured in The New York Times for Gene Therapy Breakthrough
Penn Engineering’s Liang Feng Conducts Promising Research on Nonlinear Neural Networks to Train AI on Lightspeed
New Tools for Treating Advanced Retinal Degenerations Developed by Penn Vet Researchers
Discover CAR T-cell technology at Penn
Our latest CAR T-cell enhancement portfolio features innovations poised to transform treatment efficacy with boosted cytokine activity/metabolism, streamlined manufacturing, and reduced T-cell exhaustion. Join us in turning lab discoveries into real-world impact through licensing opportunities with PCI.
Upcoming Events
All Events